Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 1953-04-4 | Product Number: G0293
Galantamine Hydrobromide
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
100MG |
€75.00
|
7 | ≥40 |
|
1G |
€481.00
|
2 | 25 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Product Number | G0293 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__7H__2__1NO__3·HBr = 368.27 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Light Sensitive,Hygroscopic,Heat Sensitive |
CAS RN | 1953-04-4 |
Related CAS RN | 357-70-0 |
Reaxys Registry Number | 3787265 |
PubChem Substance ID | 87558740 |
Merck Index (14) | 4340 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Specific rotation [a]20/D | -92.0 to -98.0 deg(C=1.4, H2O) |
Properties (reference)
Melting Point | 256 °C |
Specific Rotation | -95° (C=1.4,H2O) |
GHS
Pictogram | |
Signal Word | Danger |
Hazard Statements | H300 : Fatal if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
EC Number | 217-780-5 |
RTECS# | DF8045500 |
Transport Information:
UN Number | UN2811 |
Class | 6.1 |
Packing Group | II |
HS Number | 2939799090 |
Application
Galantamine Hydrobromide: A Unique Dual Mode Agent, an Inhibitor of Acetylcholinesterase and an Allosteric Modulator of Nicotinic Acetylcholine Receptors
Galantamine, a tertiary alkaloid found in the bulbs of Galanthus woronowi. Galantamine increases the concentration of acetylcholine (ACh) in brain tissue through competitive and reversible inhibition of its hydrolysis by acetylcholinesterase (AChE). Besides, galantamine stimulates nicotinic acetylcholine receptors (nAChR) as an allosteric potentiating ligand (APL) to enhance brain cholinergic function. Therefore, galantamine has shown potential for the treatment of Alzheimer's disease. Galantamine is metabolized in the liver via cytochrome P450 enzymes CYP2D6 and CYP3A4. (The product is for research purpose only.)
References
- Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease (a review)
- Galanthamine, a natural product for the treatment of alzheimer's disease (a review)
- Synthesis and pharmacology of galantamine
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.